Vantage Consulting Group Inc - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Vantage Consulting Group Inc ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$37,000
-14.0%
29,181
+47.7%
0.01%
+11.1%
Q3 2021$43,000
+10.3%
19,751
+89.7%
0.01%
+28.6%
Q2 2021$39,000
+2.6%
10,414
-10.9%
0.01%
-12.5%
Q1 2021$38,000
+137.5%
11,686
+150.5%
0.01%
+700.0%
Q4 2020$16,0004,6660.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders